PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Persp ...
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1580
https://www.valueinhealthjournal.com/article/S1098-3015(11)03142-1/fulltext
Title :
PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Persp ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03142-1&doi=10.1016/j.jval.2011.08.1580
First page :
A545
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
1521